Adams Samuel B, Demetracopoulos Constantine A, Queen Robin M, Easley Mark E, DeOrio James K, Nunley James A
Department of Orthopaedic Surgery, Duke University Medical Center, 4709 Creekstone Drive, Suite 200, Durham, NC 27703. E-mail address for S.B. Adams:
Michael W. Krzyzewski Human Performance Research Laboratory, DUMC 3435, Duke University Medical Center, Durham, NC 27710.
J Bone Joint Surg Am. 2014 Dec 3;96(23):1983-9. doi: 10.2106/JBJS.M.01386.
There has been a continuing increase in the use of total ankle arthroplasty for the treatment of end-stage ankle arthritis. Our aim was to determine the clinical, radiographic, and functional outcomes of total ankle arthroplasties done with a prosthesis with a modular intramedullary stem and intramedullary referencing to align the tibia.
A consecutive series of patients who underwent total ankle arthroplasty with the INBONE Total Ankle Replacement from June 2007 to December 2010 were enrolled in this study. Pain and patient-reported function were assessed with use of a visual analog scale (VAS) for pain, the American Orthopaedic Foot & Ankle Society (AOFAS) ankle-hindfoot score, the Short Musculoskeletal Function Assessment (SMFA), and the Short Form-36 (SF-36) Health Survey. Objective function was measured with assessment of walking speed, the Timed Up and Go (TUG) test, the Sit-to-Stand (STS) test, and the Four Square Step Test (4SST). Standardized weight-bearing radiographs obtained preoperatively and after total ankle arthroplasty were evaluated. We analyzed clinical, functional, and radiographic measurements with a series of repeated-measures analyses of variance (ANOVAs) with post-hoc testing to assess differences between preoperative, one-year postoperative, and most recent follow-up data. On the basis of the number of statistical comparisons, a Bonferroni correction was completed (alpha < 0.003).
We identified 194 primary INBONE total ankle arthroplasties with a mean duration of clinical follow-up of 3.7 years (range, 2.2 to 5.5 years). Patients demonstrated a significant improvement (p < 0.003) in VAS pain, AOFAS, SMFA, and SF-36 scores at the time of final follow-up, compared with preoperative values, and in walking speed, STS time, TUG time, and 4SST time at two years postoperatively, compared with preoperatively. The mean coronal tibiotalar angle for varus and valgus ankles significantly improved postoperatively and was maintained until the time of final follow-up. The prevalence of unstable subsidence leading to impending failure was 5%, and the prevalence of revision was 6%.
Patients who underwent total ankle arthroplasty with the INBONE Total Ankle Replacement demonstrated significant improvement in radiographic, functional, and patient-reported outcome scores at a mean of 3.7 years postoperatively. The overall implant survival rate was 89%.
Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
全踝关节置换术用于治疗终末期踝关节炎的应用持续增加。我们的目的是确定使用带有模块化髓内柄和髓内参考以对齐胫骨的假体进行全踝关节置换术的临床、影像学和功能结果。
本研究纳入了2007年6月至2010年12月期间连续接受INBONE全踝关节置换术的一系列患者。使用视觉模拟疼痛量表(VAS)、美国矫形足踝协会(AOFAS)踝后足评分、简短肌肉骨骼功能评估(SMFA)和简短健康调查问卷36项(SF - 36)评估疼痛和患者报告的功能。通过评估步行速度、定时起立行走测试(TUG)、坐立测试(STS)和四方步测试(4SST)来测量客观功能。评估术前和全踝关节置换术后获得的标准化负重X线片。我们使用一系列重复测量方差分析(ANOVA)及事后检验分析临床、功能和影像学测量结果,以评估术前、术后一年和最近随访数据之间的差异。根据统计比较的数量,完成了Bonferroni校正(α < 0.003)。
我们确定了194例初次INBONE全踝关节置换术,临床随访平均时长为3.7年(范围2.2至5.5年)。与术前值相比,患者在最终随访时VAS疼痛、AOFAS、SMFA和SF - 36评分有显著改善(p < 0.003),与术前相比,术后两年的步行速度、STS时间、TUG时间和4SST时间也有显著改善。内翻和外翻踝关节的平均冠状位胫距角术后显著改善,并维持到最终随访时。导致即将失败的不稳定下沉发生率为5%,翻修率为6%。
接受INBONE全踝关节置换术的患者在术后平均3.7年时,影像学、功能和患者报告的结局评分有显著改善。总体植入物生存率为89%。
治疗性IV级。有关证据水平的完整描述,请参阅作者指南。